Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG).

Khairkhah N, Owolabi H, Namvar A, Ibrahim MMH, Nyayapathy S, Jones R, Rumble JM, Whitehead CE, Sebolt-Leopold JS, Everest-Dass A, Galban S.

Open source

DOI: 10.1016/j.neo.2026.101278
Published: 2026-02-04
Container: Neoplasia
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.neo.2026.101278,
  title = {Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG).},
  author = {Khairkhah N and  Owolabi H and  Namvar A and  Ibrahim MMH and  Nyayapathy S and  Jones R and  Rumble JM and  Whitehead CE and  Sebolt-Leopold JS and  Everest-Dass A and  Galban S.},
  year = {2026},
  journal = {Neoplasia},
  doi = {10.1016/j.neo.2026.101278},
  url = {https://doi.org/10.1016/j.neo.2026.101278}
}

RIS

TY  - JOUR
TI  - Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG).
AU  - Khairkhah N
AU  -  Owolabi H
AU  -  Namvar A
AU  -  Ibrahim MMH
AU  -  Nyayapathy S
AU  -  Jones R
AU  -  Rumble JM
AU  -  Whitehead CE
AU  -  Sebolt-Leopold JS
AU  -  Everest-Dass A
AU  -  Galban S.
PY  - 2026
JO  - Neoplasia
DO  - 10.1016/j.neo.2026.101278
UR  - https://doi.org/10.1016/j.neo.2026.101278
ER  -

APA

N, K., H, O., A, N., MMH, I., S, N., R, J., JM, R., CE, W., JS, S., A, E., & S., G. (2026). Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG).. Neoplasia. https://doi.org/10.1016/j.neo.2026.101278

Source records

europe-pmc · retrieved 2026-09-25T15:23:21.248Z
doaj · retrieved 2026-09-25T15:23:21.242Z